Biotech · Private company
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Track this companyFree. Adds IDRX, Inc., a wholly owned subsidiary of GSK, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- IDRX-42Phase 1 · Gastrointestinal NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 3, 2022ClinicalTrials.gov NCT05489237 · fetched Nov 12, 2026